Quarterly figures: Merck raises annual targets after surge in results
The pharmaceutical and technology group is revising its forecast upward for the second time this year based on unexpectedly strong figures. Merck is also benefiting from the AI boom.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.